logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.
  • Medications for Haemophilus Infections

    FiltersReset Filters
    6 results
    • doxy 100

      (DOXYCYCLINE)
      Fresenius Kabi USA, LLC
      Usage: Doxycycline for Injection, USP is indicated to treat or prevent infections caused by specific susceptible bacteria, including Rickettsiae, Mycoplasma pneumoniae, and certain gram-negative and gram-positive microorganisms. It is also used for conditions like anthrax and as an alternative in cases where penicillin is contraindicated.
    • doxycycline

      (Doxycycline)
      Sun Pharmaceutical Industries Inc.
      Usage: Doxycycline tablets are indicated for treating various infections, including Rocky Mountain spotted fever, respiratory infections, chlamydial infections, and certain gram-negative and gram-positive bacterial infections. They are also used as adjunctive therapy in severe acne and acute intestinal amebiasis, and for anthrax post-exposure.
    • doxycycline hyclate

      (doxycycline hyclate)
      Slate Run Pharmaceuticals, LLC
      Usage: Doxycycline for Injection is indicated for treating or preventing infections caused by susceptible bacteria, including Rickettsiae, Mycoplasma pneumoniae, certain gram-negative and gram-positive microorganisms, and anthrax. It may also serve as an alternative when penicillin is contraindicated and can be adjunctive in acute intestinal amebiasis and trachoma treatment.
    • doxycycline hyclate

      (Doxycycline hyclate)
      Ajanta Pharma USA Inc.
      Usage: Doxycycline hyclate tablets are indicated for treating various infections, including rickettsial infections, sexually transmitted infections, respiratory tract infections, specific bacterial infections, ophthalmic infections, anthrax, and as an alternative to penicillin. They're also used adjunctively for severe acne and malaria prophylaxis in short-term travelers.
    • minocycline hydrochloride

      (Minocycline Hydrochloride)
      Sun Pharmaceutical Industries, Inc.
      Usage: Minocycline hydrochloride capsules are indicated for treating a variety of infections, including those caused by rickettsiae, Chlamydia, Mycoplasma, and certain gram-negative and gram-positive bacteria. It is also used for severe acne and as an adjunct in acute intestinal amebiasis, and to eliminate Neisseria meningitidis in carriers.
    • oseltamivir

      (OSELTAMIVIR)
      Alembic Pharmaceuticals Inc.
      Usage: Oseltamivir phosphate is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset. It is also used for prophylaxis in individuals 1 year and older. Vaccination is recommended annually and resistance may impact effectiveness.